ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,982Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 1844

$982K Total Retail Price of All Prescriptions

Rank: 50 out of 1844

606 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 14,514 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 610 552 S3 1 2
FUROSEMIDE 593 507 2 7
SIMVASTATIN 568 501 3 3
LISINOPRIL 487 467 4 4
OMEPRAZOLE 478 408 5 5
LEVOTHYROXINE SODIUM 475 419 6 1
DONEPEZIL HCL 379 379 7 26
AMLODIPINE BESYLATE 367 294 8 6
WARFARIN SODIUM 319 304 9 13
HYDROCHLOROTHIAZIDE 307 298 10 9
CITALOPRAM HBR 261 235 11 19
LANTUS 253 199 12 42
METFORMIN HCL 245 216 13 8
SERTRALINE HCL 242 205 14 21
POTASSIUM CHLORIDE 241 214 15 16
TAMSULOSIN HCL 224 209 16 27
METOPROLOL TARTRATE 217 201 17 11
NAMENDA 212 212 18 33
GABAPENTIN 200 181 19 15
CARVEDILOL 191 134 20 22
METOPROLOL SUCCINATE 168 156 21 14
LOSARTAN POTASSIUM 162 148 22 24
CYMBALTA 162 123 22 36
ATENOLOL 157 142 24 17
DIVALPROEX SODIUM 153 140 25 74
ZOLPIDEM TARTRATE 152 136 26 23
TRAZODONE HCL 148 134 27 43
PRAVASTATIN SODIUM 145 132 28 10
GLIMEPIRIDE 142 142 29 35
TRAMADOL HCL 134 95 30 18
CLOPIDOGREL 133 111 31 34
IPRATROPIUM-ALBUTEROL 126 96 32 113
HUMALOG 123 84 33 114
ADVAIR DISKUS 122 87 34 51
ALENDRONATE SODIUM 122 109 34 25
ESCITALOPRAM OXALATE 121 110 36 52
ATORVASTATIN CALCIUM 113 83 37 12
POLYETHYLENE GLYCOL 3350 112 103 38 39
ALLOPURINOL 104 95 39 29
CEFUROXIME 95 81 40 184
PLAVIX 94 83 41 61
CEPHALEXIN 94 86 41 56
RANITIDINE HCL 92 72 43 38
MELOXICAM 90 72 44 28
RISPERIDONE 87 81 45 65
LACTULOSE 86 50 46 171
FLUOXETINE HCL 81 78 47 41
TERAZOSIN HCL 81 81 47 136
DIOVAN 81 81 47 58
PANTOPRAZOLE SODIUM 80 62 50 32
DOXYCYCLINE HYCLATE 79 58 51 90
AZITHROMYCIN 78 66 52 37
DIGOXIN 76 72 53 67
PAROXETINE HCL 75 64 54 68
PREDNISONE 74 66 55 40
CLONIDINE HCL 72 57 56 64
SYNTHROID 70 44 57 55
NEXIUM 69 54 58 31
PROPRANOLOL HCL 69 56 58 129
ROPINIROLE HCL 69 52 58 76
NOVOLOG 68 47 61 84
CRESTOR 67 61 62 30
CIPROFLOXACIN HCL 65 61 63 62
FLUTICASONE PROPIONATE 63 53 64 50
CARBIDOPA-LEVODOPA 63 63 64 86
MIRTAZAPINE 61 61 66 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 59 67 20
TRIAMTERENE-HCTZ 59 58 68 48
CYCLOBENZAPRINE HCL 59 34 R 68 53
FENTANYL 59 48 S2 68 66
IBUPROFEN 59 43 68 89
SINGULAIR 58 40 72 102
ABILIFY 58 56 72 150
AMITRIPTYLINE HCL 57 22 R 74 72
OLANZAPINE 56 54 75 117
PROAIR HFA 56 44 75 45
GLYBURIDE-METFORMIN HCL 55 51 R 77 140
OXYCODONE HCL-ACETAMINOPHEN 55 41 S2 77 83
SPIRONOLACTONE 54 52 79 60
GLIPIZIDE 54 48 79 70
QUETIAPINE FUMARATE 52 24 81 82
BUSPIRONE HCL 52 52 81 127
NAPROXEN 51 29 83 87
NYSTATIN 51 37 83 85
LOSARTAN-HYDROCHLOROTHIAZIDE 50 49 85 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.